Novartis Flu Vaccine Problems Highlight Lack Of European Co-ordination
This article was originally published in The Pink Sheet Daily
Executive Summary
Quality issues that have seen two Novartis influenza vaccines suspended in a number of European countries have highlighted the shortfalls of a co-ordinated European approach to such problems.